Position
Chief Executive Officer
Company
Neurizon Therapeutics
MelbourneBiotechnologyHealth CareTherapeuticsDescription
Neurizon Therapeutics has named Dr Chris Bremer as its new CEO, bringing extensive pharmaceutical leadership experience. Bremer will oversee the company's operations during a critical phase of its drug trials for ALS.
Quick answer
Neurizon Therapeutics Appoints Dr Chris Bremer as Chief Executive Officer (September 7, 2026). Neurizon Therapeutics is based in Melbourne, Victoria, Australia.
- Who is the new Chief Executive Officer at Neurizon Therapeutics?
- Neurizon Therapeutics named Chris Bremer Chief Executive Officer, announced September 7, 2026.
- What did Neurizon Therapeutics announce on September 7, 2026?
- Neurizon Therapeutics has named Dr Chris Bremer as its new CEO, bringing extensive pharmaceutical leadership experience. Bremer will oversee the company's operations during a critical phase of its drug trials for ALS.
- What does Neurizon Therapeutics do?
- Neurizon Therapeutics is a clinical-stage company focused on developing innovative treatments.
- Where is Neurizon Therapeutics based?
- Neurizon Therapeutics is based in Melbourne, Victoria, Australia.
- Which similar companies made leadership changes around the same time?
- Abivax (September 7, 2026), Prilenia (September 8, 2026), Insitro (September 8, 2026) and Novocure (September 9, 2026) also announced leadership changes within 45 days of Neurizon Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Abivax Appoints James Berger as Global Head of Marketing (September 7, 2026)
- Prilenia Appoints Frederick (Rick) Munschauer as Chief Medical Officer (September 8, 2026)
- insitro Appoints Hideo Makimura as Chief Medical Officer (September 8, 2026)
- NovoCure Limited Announces Retirement of Director Timothy Scannell (September 9, 2026)
- Vaxcyte Appoints New Chief Legal Officer (September 4, 2026)
- Alchemab Therapeutics Appoints Dr Ben Porter-Brown as Chief Medical Officer (September 10, 2026)
Who to call at Neurizon Therapeutics, and when
A new leader at Neurizon Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Neurizon Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Neurizon Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Neurizon Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Neurizon Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Neurizon Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.